0001193125-18-332350 Sample Contracts

Fate Therapeutics, Inc. Shares of Common Stock ($0.001 par value per share) SALES AGREEMENT
Sales Agreement • November 21st, 2018 • Fate Therapeutics Inc • Biological products, (no disgnostic substances) • New York

Fate Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC (the “Agent”), as follows:

AutoNDA by SimpleDocs
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!